2nd Floor, Queens House

55/56 Lincolns Inn Fields

London WC2A 3PX

NCIN is part of the National Cancer Research Institute (NCRI)

Phone: 020 7061 8137

Fax: 020 7061 8461

E-mail: enquiries@ncin.org.uk
The NCIN is part of the National Cancer Research Institute

QuickLinks:          Commissioning Toolkit    Cancer e-Atlas     National CIS

The Cancer Reform Strategy

The NHS Cancer Reform Strategy for England, published in December 2007 builds on the progress made since the publication of the NHS Cancer Plan in 2000 and sets a clear direction for cancer services for the next five years. It shows how by 2012 our cancer services can and should become among the best in the world.

 

Download the Cancer Reform Strategy

Download the Cancer Reform Strategy - Executive summary

What the Cancer Reform Strategy means for patients

Presentation of the Cancer Reform Strategy

Letter from Professor Mike Richards

 

 
Text Box: The Cancer Reform Strategy makes some key commitments for delivery with the NCIN. These are highlighted below, with reference to the section in the Cancer Reform Strategy (CRS). NCIN Annual Report (March 2009) – (CRS 8.23) Early products (CRS – Box 42): An electronic toolkit, bringing together information on cancer in an accessible and usable way to enable the benchmarking of services and to inform commissioning; Collecting and analysing information on cancers in teenage and young adults; Evaluating services for secondary cancers in specific tumour areas; Making available to the public, information on clinical outcomes through NHS Choices; Following up on the progress of patients who have been in clinical trials over longer periods; and Assessment of trends in one year survival rates for different cancers. These are a proxy for early/late diagnosis. Management of the delivery and publication of comparative national information on diagnosis, treatment and outcomes for types of cancer and types of patient. Working with others, a new library of available information will be established and new analyses commissioned. (CRS 8.22); Development of a framework for accurate comparison (of survival and mortality, awareness, early detection, access to different forms of treatment, clinical outcomes, patient experience and costs) with other countries , closely collaborating with Europe, USA, Canada, Australia, New Zealand (CRS 11.43). Other initiatives referenced within Cancer Reform Strategy likely to require NCIN involvement: National surveys of cancer symptom awareness in collaboration with Cancer Research UK – (CRS 3.47 & 8.6); National audit in primary care of newly-diagnosed cancers in collaboration with the Royal College of General Practitioners (RCGP) and the National Patient Safety Agency (NPSA). (CRS 3.61); A new National Cancer Survivorship Initiative in partnership with Macmillan Cancer Support and other charities – (CRS 5.66); A new annual NHS Cancer Patient Experience Survey Programme – (CRS 5.73 & 8.9); National Cancer Equality Initiative to optimise data collection to enhance our understanding of the inequalities that exist. (CRS 6.8).